日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immulina® mitigates the development of illness when administered during the prodromal period of influenza viral infection in mice (Part 2)

在小鼠流感病毒感染的前驱期给予 Immulina® 可减轻疾病的发展(第二部分)

Mir, Tahir M; Shamim, Kashif; Zhang, Jin; Khan, Shabana I; Tripathi, Siddharth K; Khan, Ikhlas A; Marshall, Gailen D; Ashfaq, Mohammad K; Pugh, Nirmal D

Prophylactic and therapeutic mouse models for evaluating immunologic resilience to infection with influenza virus by Immulina® (Part 1).

使用 Immulina® 评估对流感病毒感染的免疫抵抗力的预防和治疗小鼠模型(第 1 部分)

Mir Tahir M, Shamim Kashif, Zhang Jin, Khan Shabana I, Tripathi Siddharth K, Khan Ikhlas A, Marshall Gailen D, Ashfaq Mohammad K, Pugh Nirmal D

Histomorphometric lung density evaluation of Immulina treatment using a murine influenza pneumonia model

利用小鼠流感肺炎模型对 Immulina 治疗的肺组织形态学密度进行评估

Wilson, Floyd D; Mir, Tahir M; Ashfaq, Mohammad K; Zhang, Jin; Pugh, Nirmal D; Khan, Ikhlas A; Pace, Lanny W; Hoerr, Frederic J

Comprehensive computational analysis reveals H5N1 influenza virus-encoded miRNAs and host-specific targets associated with antiviral immune responses and protein binding

综合计算分析揭示了H5N1流感病毒编码的miRNA及其与宿主特异性靶点相关的抗病毒免疫反应和蛋白质结合。

Fatima Noor ,Muhammad Hamzah Saleem ,Muhammad Rizwan Javed ,Jen-Tsung Chen ,Usman Ali Ashfaq ,Mohammad K Okla ,Mostafa A Abdel-Maksoud ,Yasmeen A Alwasel ,Wahidah H Al-Qahtani ,Huda Alshaya ,Ghulam Yasin ,Sidra Aslam